Roberts, Glore & Co’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.5M Sell
51,284
-1,586
-3% -$369K 3.44% 5
2025
Q4
$10.9M Sell
52,870
-2,364
-4% -$467K 2.91% 7
2025
Q3
$10.2M Sell
55,234
-1,597
-3% -$274K 2.8% 6
2025
Q2
$8.68M Buy
56,831
+274
+0.5% +$42.1K 2.54% 7
2025
Q1
$9.38M Sell
56,557
-1,659
-3% -$260K 2.86% 6
2024
Q4
$8.42M Buy
58,216
+243
+0.4% +$37.7K 2.5% 8
2024
Q3
$9.4M Sell
57,973
-605
-1% -$96.4K 2.72% 7
2024
Q2
$8.56M Buy
58,578
+481
+0.8% +$71.5K 2.58% 7
2024
Q1
$9.19M Sell
58,097
-2,128
-4% -$339K 2.75% 6
2023
Q4
$9.44M Sell
60,225
-186
-0.3% -$28.5K 2.94% 5
2023
Q3
$9.41M Sell
60,411
-527
-0.9% -$87K 3.11% 5
2023
Q2
$10.1M Sell
60,938
-410
-0.7% -$66.2K 3.23% 5
2023
Q1
$9.51M Sell
61,348
-145
-0.2% -$23.4K 3.18% 5
2022
Q4
$10.9M Sell
61,493
-4,536
-7% -$783K 3.77% 5
2022
Q3
$10.8M Sell
66,029
-1,109
-2% -$188K 3.86% 5
2022
Q2
$11.9M Sell
67,138
-1,080
-2% -$192K 3.97% 4
2022
Q1
$12.1M Sell
68,218
-301
-0.4% -$51.2K 3.48% 4
2021
Q4
$11.7M Buy
68,519
+474
+0.7% +$77.6K 3.08% 6
2021
Q3
$11M Sell
68,045
-194
-0.3% -$33.1K 3.34% 5
2021
Q2
$11.2M Sell
68,239
-1,050
-2% -$174K 3.36% 5
2021
Q1
$11.4M Sell
69,289
-984
-1% -$159K 3.56% 5
2020
Q4
$11.1M Buy
70,273
+302
+0.4% +$44.6K 3.61% 5
2020
Q3
$10.4M Buy
69,971
+1,461
+2% +$216K 3.71% 5
2020
Q2
$9.63M Sell
68,510
-9,402
-12% -$1.37M 3.77% 5
2020
Q1
$10.2M Buy
77,912
+245
+0.3% +$34.8K 4.37% 3
2019
Q4
$11.3M Buy
77,667
+27,276
+54% +$3.7M 4.32% 1
2019
Q3
$6.52M Sell
50,391
-890
-2% -$117K 3.99% 3
2019
Q2
$7.14M Sell
51,281
-742
-1% -$103K 4.36% 2
2019
Q1
$7.27M Sell
52,023
-20
-0% -$2.68K 4.55% 2
2018
Q4
$6.72M Sell
52,043
-1,838
-3% -$256K 4.74% 2
2018
Q3
$7.45M Buy
53,881
+1,565
+3% +$208K 4.26% 2
2018
Q2
$6.35M Sell
52,316
-1,425
-3% -$178K 3.87% 2
2018
Q1
$6.89M Buy
53,741
+104
+0.2% +$14.1K 4.25% 2
2017
Q4
$7.49M Sell
53,637
-597
-1% -$83.2K 4.58% 2
2017
Q3
$7.05M Sell
54,234
-545
-1% -$72.2K 4.56% 2
2017
Q2
$7.25M Sell
54,779
-605
-1% -$77.2K 4.83% 2
2017
Q1
$6.9M Sell
55,384
-2,660
-5% -$318K 4.75% 2
2016
Q4
$6.69M Sell
58,044
-470
-0.8% -$54.3K 4.66% 2
2016
Q3
$6.91M Sell
58,514
-1,186
-2% -$144K 4.97% 2
2016
Q2
$7.24M Sell
59,700
-1,193
-2% -$136K 5.49% 2
2016
Q1
$6.59M Sell
60,893
-358
-0.6% -$37.1K 4.99% 2
2015
Q4
$6.29M Sell
61,251
-286
-0.5% -$28.8K 4.76% 2
2015
Q3
$5.74M Sell
61,537
-260
-0.4% -$25.2K 4.48% 2
2015
Q2
$6.02M Sell
61,797
-300
-0.5% -$30K 4.21% 3
2015
Q1
$6.25M Sell
62,097
-125
-0.2% -$12.7K 4.31% 3
2014
Q4
$6.51M Buy
62,222
+206
+0.3% +$21.7K 4.34% 2
2014
Q3
$6.61M Sell
62,016
-490
-0.8% -$50.8K 4.58% 2
2014
Q2
$6.54M Sell
62,506
-2,555
-4% -$258K 4.43% 2
2014
Q1
$6.39M Buy
65,061
+217
+0.3% +$20.1K 4.41% 2
2013
Q4
$5.94M Sell
64,844
-895
-1% -$82.5K 4.11% 3
2013
Q3
$5.7M Sell
65,739
-18,678
-22% -$1.68M 4.21% 4
2013
Q2
$7.25M Buy
+84,417
New +$7.16M 4.47% 3

Other funds holding JNJ

Roberts, Glore & Co's JNJ Position: Q1 2026 in Review

Roberts, Glore & Co reduced its Johnson & Johnson (JNJ) stake by 3% in Q1 2026, selling an estimated $369K and leaving 51,284 shares worth $12.5M. The position accounts for 3.44% of the portfolio, ranked #5.

Roberts, Glore & Co first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Roberts, Glore & Co held 51,284 shares of Johnson & Johnson worth $12.5M as of Q1 2026.
  • Roberts, Glore & Co sold 1,586 Johnson & Johnson shares in Q1 2026, an estimated $369K.
  • Johnson & Johnson made up 3.44% of Roberts, Glore & Co's portfolio in Q1 2026, its #5 holding.
  • Roberts, Glore & Co first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Roberts, Glore & Co's 13F filing for Q1 2026, filed 4 May 2026.